Terns Pharmaceuticals Statistics

Total Valuation

TERN has a market cap or net worth of $294.81 million. The enterprise value is $31.97 million.

Market Cap	294.81M
Enterprise Value	31.97M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

TERN has 64.65 million shares outstanding. The number of shares has increased by 97.76% in one year.

Shares Outstanding	64.65M
Shares Change (YoY)	+97.76%
Shares Change (QoQ)	+1.14%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	111.30%
Float	26.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.15
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.39, with a Debt / Equity ratio of 0.00.

Current Ratio	22.39
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.50% and return on invested capital (ROIC) is -40.07%.

Return on Equity (ROE)	-33.50%
Return on Assets (ROA)	-31.90%
Return on Capital (ROIC)	-40.07%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	66
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TERN has paid $239,000 in taxes.

Income Tax	239,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.43% in the last 52 weeks. The beta is -0.65, so TERN's price volatility has been lower than the market average.

Beta (1Y)	-0.65
52-Week Price Change	-65.43%
50-Day Moving Average	6.61
200-Day Moving Average	5.98
Relative Strength Index (RSI)	30.85
Average Volume (30 Days)	896,979

Short Selling Information

The latest short interest is 4.49 million, so 6.95% of the outstanding shares have been sold short.

Short Interest	4.49M
Short Previous Month	4.23M
Short % of Shares Out	6.95%
Short % of Float	16.68%
Short Ratio (days to cover)	3.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-102.56M
Pretax Income	-89.97M
Net Income	-90.21M
EBITDA	-89.09M
EBIT	-89.97M
Earnings Per Share (EPS)	-$1.27

Full Income Statement

Balance Sheet

The company has $263.44 million in cash and $603,000 in debt, giving a net cash position of $262.84 million or $4.07 per share.

Cash & Cash Equivalents	263.44M
Total Debt	603,000
Net Cash	262.84M
Net Cash Per Share	$4.07
Equity / Book Value	255.37M
Book Value Per Share	3.95
Working Capital	255.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.39 million and capital expenditures -$52,000, giving a free cash flow of -$67.44 million.

Operating Cash Flow	-67.39M
Capital Expenditures	-52,000
Free Cash Flow	-67.44M
FCF Per Share	-$0.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TERN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.76%
Shareholder Yield	-97.76%
Earnings Yield	-30.60%
FCF Yield	-22.88%

Analyst Forecast

The average price target for TERN is $14.94, which is 227.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.94
Price Target Difference	227.63%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-3.97%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1